MC 1288
Alternative Names: 20-Epi-1,25-dihydroxyvitamin-D3Latest Information Update: 25 Jul 2001
At a glance
- Originator LEO Pharma
- Developer LEO Pharma; Nonindustrial source
- Class Antineoplastics; Antipsoriatics; Osteoporosis therapies; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Renal transplant rejection; Rheumatoid arthritis; Transplant rejection; Type 1 diabetes mellitus
Most Recent Events
- 25 Jul 2001 Discontinued-Preclinical for Autoimmune disorders in Denmark (Unknown route)
- 25 Jul 2001 Discontinued-Preclinical for Renal transplant rejection in Finland (Unknown route)
- 25 Jul 2001 Discontinued-Preclinical for Rheumatoid arthritis in Sweden (Unknown route)